Suppression of immunological response against a transgene product delivered from microencapsulated cells

Human Gene Therapy

Volumn 9, Issue 9, 1998, Pages 1275-1282

  Potter, Murray A ^b   Hymus, Stephanie ^b   Stockley, Tracy ^a,b   Chang, Patricia L ^b  

^a Canadian Red Cross Society   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; GROWTH HORMONE ANTIBODY; HUMAN GROWTH HORMONE; INTERLEUKIN 12; MONOCLONAL ANTIBODY; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; IMMUNOSUPPRESSIVE TREATMENT; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; TRANSGENE;

ANIMALIA;

EID: 0032503629     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.9-1275     Document Type: Article

References (15)

1. ABBAS, A.K., LICHTMAN, A.H., and POBER, J.S. (1994). Cellular and Molecular Immunology. (W.B. Saunders & Co., Philaldephia).
2. AL-HENDY, A., HORTELANO, G., TANNENBAUM, G.S., and CHANG, P.L. (1995). Allogeneic somatic gene therapy: Correction of growth hormone deficiency in mice with microencapsulted non-autologous myoblasts. Hum. Gene Ther. 6, 165-175.
3. ALLAIN, J. (1984). Transfusion support for hemophiliacs. Clinics Haematol. 13, 99-117.
4. BOWIE, K.M. (1997). "Differentiation of recombinant myoblasts in alginate microcapsules." M.Sc. Thesis, McMaster University, Hamilton, Ontario, Canada.
5. CHANG, P.L. (1995). Nonautologous somatic gene therapy. In Somatic Gene Therapy. P.L. Chang, ed. (CRC Press, Inc., Florida) pp. 203-223.
6. CHANG, P.L., CAPONE, J.P., and BROWN, G.M. (1990). Autologous fibroblast implantation: Feasibility and potential problems in gene replacement therapy. Mol. Bio. Med. 7, 461-470.
7. CHANG, P.L., SHEN, N., and WESTCOTT, A.J. (1993). Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4, 433-440.
8. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W.W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
9. FOY, T.M., SHEPHERD, D.M., DURIE, F.H., ARUFFO, A., LEDBETTER, J.A., and NOELLE, R.J. (1993). In vivo CD40-gp39 interactions are essential for thymus dependent humoral immunity: prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178, 1567-1575.
10. GRABOWSKI, G.A., BARTON, N.W., PASTORES, G., DAMBROSIA, J.M., BANERJEE, T.K., MCKEE, M.A., PARKER, C., SCHIFFMANN, R., HILL, S.C., and BRADY, R.O. (1995). Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann. Intern. Med. 122, 33-39.
11. HORTELANO, G., AL-HENDY, A., OFOSU, F.A. and CHANG, P.L. (1996). Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood 87, 5095-5103.
12. H2 cytokines in the central nervous system. J. Immunol. 155, 4521-4524.
13. TURYN, D., and BARTKE (1993). Pharmacokinetics of radioiodinated human and bovine growth hormones in mice expressing bovine growth hormone. Transgenic Rev. 2, 219-226.
14. YANG, Y., TRINCHIERI, G., and WILSON, J.M. (1995). Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1, 890-893.
15. YANG, Y., GREENOUGH, K., and WILSON, J.M. (1996). Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3, 412-420.